To qualify for fast track approval, a drug must show potential to address unmet medical needs. Specifically, the drug should demonstrate some advantage over existing treatments, such as improved survival rates, fewer side effects, or better quality of life. The drug developer must provide preliminary clinical data supporting these claims.
